Jamjoom Pharmaceuticals Factory Company (TADAWUL: 4015)
Saudi Arabia
· Delayed Price · Currency is SAR 156.20
-1.20 (-0.76%)
Dec 19, 2024, 3:14 PM AST
Jamjoom Pharmaceuticals Factory Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | 349.4 | 292.4 | 171.31 | 170.7 | 206.86 | 156.93 | Upgrade
|
| Depreciation & Amortization | 33.94 | 26.15 | 24.37 | 24.08 | 42.23 | 42.11 | Upgrade
|
| Other Amortization | 0.48 | 0.48 | 0.36 | 0.27 | 0.26 | 0.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.21 | 1.26 | 1.22 | -0.09 | -0.09 | -0.32 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 2.11 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 2.41 | - | - | 2.08 | 8.32 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -16.17 | -4.41 | 0.32 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 1.88 | 2.1 | 2.35 | 2.25 | -1.05 | -0.09 | Upgrade
|
| Other Operating Activities | 28.27 | 27.37 | 54.79 | 2.97 | 22.95 | 21.65 | Upgrade
|
| Change in Accounts Receivable | -124.2 | 18.03 | 12.19 | 46.74 | 7.92 | -57.04 | Upgrade
|
| Change in Inventory | -69.36 | -114.43 | -7.52 | -16.71 | -48.8 | 31.79 | Upgrade
|
| Change in Accounts Payable | 109.86 | 44.53 | -11.54 | -3.59 | 21.23 | 8.1 | Upgrade
|
| Change in Other Net Operating Assets | -7.61 | 2.55 | -18.53 | - | - | - | Upgrade
|
| Operating Cash Flow | 310.11 | 296.03 | 229.33 | 228.7 | 261.93 | 203.58 | Upgrade
|
| Operating Cash Flow Growth | 50.92% | 29.09% | 0.28% | -12.69% | 28.67% | 80.62% | Upgrade
|
| Capital Expenditures | -55.48 | -45.18 | -86.12 | -126.79 | -148.52 | -68.4 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.39 | 0.05 | 0.15 | 0.14 | 0.14 | 0.97 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.07 | -0.6 | -1.53 | -0.02 | -15.09 | -0.46 | Upgrade
|
| Investment in Securities | -5.6 | -31.72 | 33.02 | -19.08 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | 2.48 | -15.02 | - | Upgrade
|
| Investing Cash Flow | -60.77 | -77.44 | -54.48 | -143.26 | -178.49 | -70.02 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 78.2 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.35 | -0.35 | -95.02 | -16 | -14 | Upgrade
|
| Net Debt Issued (Repaid) | -0.36 | -0.35 | -0.35 | -95.02 | 62.2 | -14 | Upgrade
|
| Common Dividends Paid | -217 | -70 | -148.78 | -113.33 | -90.67 | -86 | Upgrade
|
| Financing Cash Flow | -217.36 | -70.35 | -149.13 | -208.35 | -28.47 | -100 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6.19 | -5.14 | 2.83 | - | - | - | Upgrade
|
| Net Cash Flow | 25.79 | 143.09 | 28.55 | -122.92 | 54.97 | 33.55 | Upgrade
|
| Free Cash Flow | 254.63 | 250.85 | 143.2 | 101.9 | 113.41 | 135.18 | Upgrade
|
| Free Cash Flow Growth | 64.42% | 75.17% | 40.53% | -10.15% | -16.10% | 105.11% | Upgrade
|
| Free Cash Flow Margin | 20.09% | 22.79% | 15.62% | 13.85% | 14.08% | 18.47% | Upgrade
|
| Free Cash Flow Per Share | 3.64 | 3.58 | 2.05 | 10.19 | 11.34 | 13.52 | Upgrade
|
| Cash Interest Paid | 18.36 | 1.19 | 13.23 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 143.29 | 155.43 | 84.13 | 50.95 | 2.62 | 70.92 | Upgrade
|
| Unlevered Free Cash Flow | 143.36 | 155.5 | 84.2 | 50.95 | 2.62 | 70.92 | Upgrade
|
| Change in Net Working Capital | 67.53 | 22.77 | 4.41 | -37.28 | 26.2 | 11.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.